Attitudes of patients to their seizure medication and a possible withdrawal - EPAMA study
Recruiting
- Conditions
- EPILEPSY
- Registration Number
- DRKS00030094
- Lead Sponsor
- Klinik für Neurologie mit experimenteller Neurologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
We will include:
- Patients with confirmed epilepsy
- Age = 18 years
- Seizure freedom for 2 years prior to enrollment
Exclusion Criteria
We will exclude:
- Patients who are not able to consent
- Patients without sufficient knowledge of German
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We will ask all patients of the epilepsy outpatient clinic at the Charite who have been seizure-free for 2 years from October 1, 2022 to October 1, 2023 to if they want to participate in our study. We will ask for reasons whether antiseizure medication would like to be withdrawn. In addition, we ask about general quality of life, depression, personality type, and anxiety.
- Secondary Outcome Measures
Name Time Method We have no secondary outcomes.